[Federal Register Volume 65, Number 199 (Friday, October 13, 2000)]
[Notices]
[Pages 60977-60978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-26367]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 1, 2000, and published in the Federal Register 
on May 12, 2000, (65 FR 30614), Dupont Pharmaceuticals, 1000 Stewart 
Avenue, Garden City, New York 11530, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of

[[Page 60978]]

the basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished products.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Dupont 
Pharmaceuticals to manufacture the listed controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Dupont Pharmaceuticals on a regular basis to ensure that the company's 
continued registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: August 18, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-26367 Filed 10-12-00; 8:45 am]
BILLING CODE 4410-09-M